✦ LIBER ✦

Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities

✍ Scribed by Patrizia Fabbi; Giorgio Ghigliotti; Claudio Brunelli; Manrico Balbi; Paolo Spallarossa; Pierfranco Rossettin; Antonio Barsotti; Patrizio Odetti; Silvano Garibaldi

Book ID: 113772432
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 176 KB
Volume: 143
Category: Article
ISSN: 1532-6543
DOI: 10.1016/j.lab.2003.10.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Visfatin is associated with lipid metabo

Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats

✍ Pei Wang; Chong Bai; Quan-Yi Xu; Tian-Ying Xu; Ding-Feng Su; Jean Sassard; Chao- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

Prevalence of the metabolic syndrome is

Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis

✍ Cecilia P. Chung; Annette Oeser; Joseph F. Solus; Ingrid Avalos; Tebeb Gebretsad 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 174 KB

62 CIRCULATING PENTRAXIN 3 IS INCREASED

62 CIRCULATING PENTRAXIN 3 IS INCREASED IN METABOLIC SYNDROME PATIENTS: ASSOCIATIONS WITH ATHEROGENIC LIPID PROFILE AND SUBCLINICAL ATHEROSCLEROSIS

✍ G. Lovero; R. Barazzoni; C. Ferreira; C. Bosutti; M. Fonda; M. Valente; L. Catti 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Measures of insulin resistance add incre

Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis

✍ M.P. Reilly; M.L. Wolfe; T. Rhodes 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 44 KB

P344 CIRCULATING PENTRAXIN 3 IS INCREASE

P344 CIRCULATING PENTRAXIN 3 IS INCREASED IN METABOLIC SYNDROME PATIENTS: ASSOCIATIONS WITH ATHEROGENIC LIPID PROFILE AND SUBCLINICAL ATHEROSCLEROSIS

✍ M. Zanetti; R. Barazzoni; A. Bosutti; C. Ferreira; P. Vinci; M. Fonda; M. Valent 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

INTENSIVE LIPID LOWERING WITH ATORVASTAT

INTENSIVE LIPID LOWERING WITH ATORVASTATIN IS ASSOCIATED WITH SIGNIFICANT CARDIOVASCULAR BENEFITS IN CORONARY PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE

✍ Shepherd, J.; Wenger, N.K.; Carmena, R.; Deedwania, P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 137 KB